Bodyweight Interval Exercise in the Fed Versus Fasted State (BWE)

January 25, 2024 updated by: Jenna Gillen, University of Toronto

Bodyweight Interval Exercise in the Fed Versus Fasted State on Postprandial Glycemia, Appetite Perceptions and Fat Oxidation

The purpose of this study is to investigate the effects of a single session of at-home bodyweight interval exercise, performed in the fasted or fed state, on postprandial glycemic management, post-exercise fat oxidation, and overall perceptions of appetite in recreationally active females. This is a remote/online study and does not involve any visits to the laboratory.

Study Overview

Status

Completed

Conditions

Detailed Description

Following the acquisition of informed consent via videoconferencing, eligibility to participate in the study will be determined using questionnaires. If inclusion criteria is met, participants will undergo virtual exercise familiarization by following a pre-recorded instructional video.

Eligible participants will be assigned, in a random order, to two metabolic trials at least 3 days apart in the follicular phase of the same menstrual cycle. These visits will be online with an investigator on videoconferencing. The two trials involve: 1) Exercise followed by breakfast; and 2) Breakfast followed by exercise.

Various outcomes will be measured throughout the metabolic trials including: blood sugar, fat oxidation and appetite. All research tools needed to acquire these methods will be delivered to participants' place of residence.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S 2C9
        • Goldring Centre for High Performance Sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Females 18-35 years
  • Recreationally active (complete <150 min of exercise 1-3 days per week) and not training for any specific sport
  • Experiencing monthly menstrual periods (eumenorrheic)
  • Are not currently on oral contraceptives, or are taking triphasic oral contraceptives
  • Body mass index (BMI) ≥18.5 kg/m2 and ≤30 kg/m2
  • Regular consumption of a breakfast meal (solid and liquid meals apply) most (≥ 4) days of the week
  • Have a device compatible for use with study applications (e.g., smart phone)

Exclusion Criteria:

  • Inability to safely perform physical activity as determined by the Get Active Questionnaire
  • Not willing to consume the standardized test drink before and after exercise
  • Sensitive to meal timing around exercise (e.g., gastrointestinal issues if exercise performed 10 min after the start of meal consumption or if a meal is consumed 5 min after exercise)
  • Inability to adhere to pre-trial protocol guidelines (e.g., caffeine or alcohol restrictions)
  • Physical limitations for bodyweight exercise
  • Are on monophasic or biphasic oral contraceptives
  • Regular tobacco or cannabis use (e.g., recreational and/or medical cannabis, cigarettes, e-cigarettes, vape pens, JUUL)
  • Regular use of drugs that may alter metabolism (e.g., corticosteroids, nSAIDs)
  • Diagnosed medical condition under the care of care of a physician (e.g., type 2 diabetes, cardiovascular disease) Currently enrolled in a course with Dr. Gillen

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fasted Exercise
Exercise followed by breakfast
Bodyweight interval exercise performed 5 minutes before the start of a mixed-macronutrient breakfast meal
Experimental: Fed Exercise
Breakfast followed by exercise
Bodyweight interval exercise performed 10 minutes after the start of consuming a mixed-macronutrient breakfast meal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average blood glucose concentration
Time Frame: 2 hours
Average blood glucose concentration during postprandial period
2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood glucose concentration
Time Frame: 2 hours
Blood glucose concentration across postprandial period
2 hours
Blood glucose area under the curve
Time Frame: 2 hours
blood glucose area under the curve during postprandial period
2 hours
Peak blood glucose concentration
Time Frame: 2 hours
peak glucose across postprandial period
2 hours
Post-exercise fat oxidation
Time Frame: pre-exercise, immediately post-exercise, up to 3 hours post-exercise
post-exercise fat oxidation measured as percent carbon dioxide
pre-exercise, immediately post-exercise, up to 3 hours post-exercise
Appetite Perceptions
Time Frame: pre-exercise, immediately post-exercise, and 1, 2 and 3 hours post-exercise
Visual analog scales (0-100) will be used to determine perceptions of hunger, satisfaction, fullness, and prospective food consumption with higher scores denoting increased perceptions.
pre-exercise, immediately post-exercise, and 1, 2 and 3 hours post-exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jenna Gillen, PhD, University of Toronto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 14, 2021

Primary Completion (Actual)

August 30, 2021

Study Completion (Actual)

August 30, 2021

Study Registration Dates

First Submitted

January 14, 2024

First Submitted That Met QC Criteria

January 25, 2024

First Posted (Estimated)

February 5, 2024

Study Record Updates

Last Update Posted (Estimated)

February 5, 2024

Last Update Submitted That Met QC Criteria

January 25, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 40799

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Fasted exercise

3
Subscribe